Ten‐year outcomes of anti‐vascular endothelial growth factor treatment for neovascular age‐related macular disease: A single‐centre French study-Reference-Cited by-同舟云学术

Ten‐year outcomes of anti‐vascular endothelial growth factor treatment for neovascular age‐related macular disease: A single‐centre French study

Published:2020-03-16 Issue:5 Volume:48 Page:636-643
ISSN:1442-6404
Container-title:Clinical & Experimental Ophthalmology
language:en
Short-container-title:Clin Experiment Ophthalmol

Author:

Wolff Benjamin¹^ORCID,Macioce Valerie²,Vasseur Vivien¹³,Castelnovo Laurent¹,Michel Guillaume¹,Nguyen Vuong⁴^ORCID,Daien Vincent⁵⁶^ORCID,Mauget‐Faÿsse Martine³,Gillies Mark⁴

Affiliation:

1. Maison Rouge Ophthalmologic Centre Strasbourg France

2. Clinical Research and Epidemiology Unit CHU Montpellier, University of Montpellier Montpellier France

3. Research Department Rothschild Foundation Paris France

4. The Save Sight Institute, Sydney Medical School The University of Sydney Sydney Australia

5. Department of Ophthalmology Gui de Chauliac Hospital Montpellier France

6. Inserm, U1061 Montpellier France

Publisher

Wiley

Subject

Ophthalmology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ceo.13742

Reference28 articles.

1. Age-related macular degeneration

2. Resolution of subretinal haemorrhage and fluid after intravitreal bevacizumab in aggressive peripapillary subretinal neovascularization

3. Two-Year Outcomes of “Treat and Extend” Intravitreal Therapy for Neovascular Age-Related Macular Degeneration

4. Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON

5. An 8-year follow-up of anti-vascular endothelial growth factor treatment with a treat-and-extend modality for neovascular age-related macular degeneration

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the role of granzyme B in subretinal fibrosis of age-related macular degeneration;Frontiers in Immunology;2024-07-18

2. The complement pathway as a therapeutic target for neovascular age-related macular degeneration-mediated subretinal fibrosis;Current Opinion in Pharmacology;2024-06

3. Long-term results of treatment of neovascular age-related macular degeneration using antiangiogenic drugs: A review of the literature;Archivos de la Sociedad Española de Oftalmología (English Edition);2024-05

4. Resultados a largo plazo del tratamiento de la degeneración macular asociada a la edad neovascular mediante fármacos antiangiogénicos: revisión de la bibliografía;Archivos de la Sociedad Española de Oftalmología;2023-12

5. Vascular Cell Adhesion Molecule-1 (VCAM-1) contributes to macular fibrosis in neovascular age-related macular degeneration through modulating macrophage functions;Immunity & Ageing;2023-11-20